Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen

Summary An emerging paradigm in vaccinology is that multiple adjuvant combinations may be more effective than individual adjuvants in enhancing immune responses to vaccine antigens. We investigated whether the polyphosphazenes used in combination with CpG oligodeoxynucleotides (ODN) were potent adju...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine Vol. 26; no. 22; pp. 2680 - 2688
Main Authors: Mutwiri, George, Benjamin, Ponn, Soita, Henry, Babiuk, Lorne A
Format: Journal Article
Language:English
Published: Oxford Elsevier Ltd 23-05-2008
Elsevier
Elsevier Limited
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Summary An emerging paradigm in vaccinology is that multiple adjuvant combinations may be more effective than individual adjuvants in enhancing immune responses to vaccine antigens. We investigated whether the polyphosphazenes used in combination with CpG oligodeoxynucleotides (ODN) were potent adjuvant formulations. BALB/c mice were immunized subcutaneously with Hepatitis B surface antigen (HBsAg) alone, or in various combinations with poly[di(sodium carboxylatophenoxy)phosphazene] (PCPP), poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) or CpG ODN. All three adjuvants enhanced HBsAg-specific IgG1 antibody responses with PCEP inducing the highest responses. PCEP and CpG ODN significantly enhanced the Th1-associated antibody isotype IgG2a. As expected CpG ODN induced predominantly Th1-type immune responses while PCEP was associated with mixed Th1/Th2 immune responses. Interestingly, PCEP and PCPP synergized with CpG ODN to further enhance antibody responses. Since the mechanisms which mediate the adjuvant activity of polyphosphazenes are not fully understood, we investigated whether PCEP and PCPP could stimulate innate immune responses. Incubation of mouse splenocytes with PCEP or PCPP (in the absence of antigen) stimulated production of IL-4 and IL-12, but only PCEP induced significant IFNγ production. Additionally, IL-12 was not required for PCEP induced IFNγ response. We conclude that the polyphosphazene–CpG ODN combination is a potent adjuvant formulation that is more effective in enhancing immune responses than either of the individual adjuvants. In addition, we provide evidence that PCEP and PCPP can stimulate innate cytokine production, suggesting a potential mechanism by which polyphosphazenes achieve their potent adjuvant effects.
AbstractList An emerging paradigm in vaccinology is that multiple adjuvant combinations may be more effective than individual adjuvants in enhancing immune responses to vaccine antigens. We investigated whether the polyphosphazenes used in combination with CpG oligodeoxynucleotides (ODN) were potent adjuvant formulations. BALB/c mice were immunized subcutaneously with Hepatitis B surface antigen (HBsAg) alone, or in various combinations with poly[di(sodium carboxylatophenoxy)phosphazene] (PCPP), poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) or CpG ODN. All three adjuvants enhanced HBsAg-specific IgG1 antibody responses with PCEP inducing the highest responses. PCEP and CpG ODN significantly enhanced the Th1-associated antibody isotype IgG2a. As expected CpG ODN induced predominantly Th1-type immune responses while PCEP was associated with mixed Th1/Th2 immune responses. Interestingly, PCEP and PCPP synergized with CpG ODN to further enhance antibody responses. Since the mechanisms which mediate the adjuvant activity of polyphosphazenes are not fully understood, we investigated whether PCEP and PCPP could stimulate innate immune responses. Incubation of mouse splenocytes with PCEP or PCPP (in the absence of antigen) stimulated production of IL-4 and IL-12, but only PCEP induced significant IFNgamma production. Additionally, IL-12 was not required for PCEP induced IFNgamma response. We conclude that the polyphosphazene-CpG ODN combination is a potent adjuvant formulation that is more effective in enhancing immune responses than either of the individual adjuvants. In addition, we provide evidence that PCEP and PCPP can stimulate innate cytokine production, suggesting a potential mechanism by which polyphosphazenes achieve their potent adjuvant effects.
An emerging paradigm in vaccinology is that multiple adjuvant combinations may be more effective than individual adjuvants in enhancing immune responses to vaccine antigens. We investigated whether the polyphosphazenes used in combination with CpG oligodeoxynucleotides (ODN) were potent adjuvant formulations. BALB/c mice were immunized subcutaneously with Hepatitis B surface antigen (HBsAg) alone, or in various combinations with poly[di(sodium carboxylatophenoxy)phosphazene] (PCPP), poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) or CpG ODN. All three adjuvants enhanced HBsAg-specific IgG1 antibody responses with PCEP inducing the highest responses. PCEP and CpG ODN significantly enhanced the Th1-associated antibody isotype IgG2a. As expected CpG ODN induced predominantly Th1-type immune responses while PCEP was associated with mixed Th1/Th2 immune responses. Interestingly, PCEP and PCPP synergized with CpG ODN to further enhance antibody responses. Since the mechanisms which mediate the adjuvant activity of polyphosphazenes are not fully understood, we investigated whether PCEP and PCPP could stimulate innate immune responses. Incubation of mouse splenocytes with PCEP or PCPP (in the absence of antigen) stimulated production of IL-4 and IL-12, but only PCEP induced significant IFNγ production. Additionally, IL-12 was not required for PCEP induced IFNγ response. We conclude that the polyphosphazene-CpG ODN combination is a potent adjuvant formulation that is more effective in enhancing immune responses than either of the individual adjuvants. In addition, we provide evidence that PCEP and PCPP can stimulate innate cytokine production, suggesting a potential mechanism by which polyphosphazenes achieve their potent adjuvant effects.
Summary An emerging paradigm in vaccinology is that multiple adjuvant combinations may be more effective than individual adjuvants in enhancing immune responses to vaccine antigens. We investigated whether the polyphosphazenes used in combination with CpG oligodeoxynucleotides (ODN) were potent adjuvant formulations. BALB/c mice were immunized subcutaneously with Hepatitis B surface antigen (HBsAg) alone, or in various combinations with poly[di(sodium carboxylatophenoxy)phosphazene] (PCPP), poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) or CpG ODN. All three adjuvants enhanced HBsAg-specific IgG1 antibody responses with PCEP inducing the highest responses. PCEP and CpG ODN significantly enhanced the Th1-associated antibody isotype IgG2a. As expected CpG ODN induced predominantly Th1-type immune responses while PCEP was associated with mixed Th1/Th2 immune responses. Interestingly, PCEP and PCPP synergized with CpG ODN to further enhance antibody responses. Since the mechanisms which mediate the adjuvant activity of polyphosphazenes are not fully understood, we investigated whether PCEP and PCPP could stimulate innate immune responses. Incubation of mouse splenocytes with PCEP or PCPP (in the absence of antigen) stimulated production of IL-4 and IL-12, but only PCEP induced significant IFNγ production. Additionally, IL-12 was not required for PCEP induced IFNγ response. We conclude that the polyphosphazene–CpG ODN combination is a potent adjuvant formulation that is more effective in enhancing immune responses than either of the individual adjuvants. In addition, we provide evidence that PCEP and PCPP can stimulate innate cytokine production, suggesting a potential mechanism by which polyphosphazenes achieve their potent adjuvant effects.
An emerging paradigm in vaccinology is that multiple adjuvant combinations may be more effective than individual adjuvants in enhancing immune responses to vaccine antigens. We investigated whether the polyphosphazenes used in combination with CpG oligodeoxynucleotides (ODN) were potent adjuvant formulations. BALB/c mice were immunized subcutaneously with Hepatitis B surface antigen (HBsAg) alone, or in various combinations with poly[di(sodium carboxylatophenoxy)phosphazene] (PCPP), poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) or CpG ODN. All three adjuvants enhanced HBsAg-specific IgG1 antibody responses with PCEP inducing the highest responses. PCEP and CpG ODN significantly enhanced the Th1-associated antibody isotype IgG2a. As expected CpG ODN induced predominantly Th1-type immune responses while PCEP was associated with mixed Th1/Th2 immune responses. Interestingly, PCEP and PCPP synergized with CpG ODN to further enhance antibody responses. Since the mechanisms which mediate the adjuvant activity of polyphosphazenes are not fully understood, we investigated whether PCEP and PCPP could stimulate innate immune responses. Incubation of mouse splenocytes with PCEP or PCPP (in the absence of antigen) stimulated production of IL-4 and IL-12, but only PCEP induced significant IFNg production. Additionally, IL-12 was not required for PCEP induced IFNg response. We conclude that the polyphosphazene-CpG ODN combination is a potent adjuvant formulation that is more effective in enhancing immune responses than either of the individual adjuvants. In addition, we provide evidence that PCEP and PCPP can stimulate innate cytokine production, suggesting a potential mechanism by which polyphosphazenes achieve their potent adjuvant effects.
An emerging paradigm in vaccinology is that multiple adjuvant combinations may be more effective than individual adjuvants in enhancing immune responses to vaccine antigens. We investigated whether the polyphosphazenes used in combination with CpG oligodeoxynucleotides (ODN) were potent adjuvant formulations. BALB/c mice were immunized subcutaneously with Hepatitis B surface antigen (HBsAg) alone, or in various combinations with poly[di(sodium carboxylatophenoxy)phosphazene] (PCPP), poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) or CpG ODN. All three adjuvants enhanced HBsAg-specific IgG1 antibody responses with PCEP inducing the highest responses. PCEP and CpG ODN significantly enhanced the Th1-associated antibody isotype IgG2a. As expected CpG ODN induced predominantly Th1-type immune responses while PCEP was associated with mixed Th1/Th2 immune responses. Interestingly, PCEP and PCPP synergized with CpG ODN to further enhance antibody responses. Since the mechanisms which mediate the adjuvant activity of polyphosphazenes are not fully understood, we investigated whether PCEP and PCPP could stimulate innate immune responses. Incubation of mouse splenocytes with PCEP or PCPP (in the absence of antigen) stimulated production of IL-4 and IL-12, but only PCEP induced significant IFN gamma production. Additionally, IL-12 was not required for PCEP induced IFN gamma response. We conclude that the polyphosphazene-CpG ODN combination is a potent adjuvant formulation that is more effective in enhancing immune responses than either of the individual adjuvants. In addition, we provide evidence that PCEP and PCPP can stimulate innate cytokine production, suggesting a potential mechanism by which polyphosphazenes achieve their potent adjuvant effects.
Author Mutwiri, George
Babiuk, Lorne A
Soita, Henry
Benjamin, Ponn
Author_xml – sequence: 1
  fullname: Mutwiri, George
– sequence: 2
  fullname: Benjamin, Ponn
– sequence: 3
  fullname: Soita, Henry
– sequence: 4
  fullname: Babiuk, Lorne A
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20328867$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/18430493$$D View this record in MEDLINE/PubMed
BookMark eNqFklGL1DAQx4OceHurH0EpiOJL10nSbLMvii56Jxz4oIJvIU2nu1nbpJe0q3ufxo9qyi4e3INCIJD5zX9m8p8Lcua8Q0KeUlhQoMvXu8VeG2MdLhiAXABPhz4gMypLnjNB5RmZAVsWeUHh-zm5iHEHAILT1SNyTmXBoVjxGfm99rmuO-tsHIIerHeZb7Let4d-62O_1bfoMGY_7bDN1v1l5lu78TX6Xwc3mhb9YOsUTrnebdpDhm6rnUkvtutGh1nA2HsXpweXddbgMWBvsT5qXmGfqg42Zu-zvQ1j0hpDoxOo3WA36B6Th41uIz453XPy7eOHr-ur_Prz5af1u-vciAKGXK4MVsUKGNeGL7XWQnMOEmVtZFUuURS0ZjXISlAQskGhTSUbVnPNaCmg4nPy8qjbB38zYhxUZ6PBttUO_RgVg1W5AsoS-OqfIBUApZS0kAl9fg_d-TG4NEaixMSUyYg5EUfKBB9jwEb1wXY6HBQFNXmtdurktZq8VsDToSnv2Ul9rDqs77JO5ibgxQnQ0ei2CckaG_9yDDiTclkm7u2Rw_S_e4tBRWMx2VjbgGZQtbf_beXNPQXTppVKRX_gAePd1CoyBerLtJjTXoIE4Dw18gc0e-Sq
CODEN VACCDE
CitedBy_id crossref_primary_10_1016_j_addr_2008_12_004
crossref_primary_10_1016_j_vaccine_2015_12_060
crossref_primary_10_1016_j_addr_2008_12_003
crossref_primary_10_1080_21645515_2021_1875763
crossref_primary_10_1016_j_addr_2008_12_009
crossref_primary_10_1016_j_vaccine_2016_12_023
crossref_primary_10_1128_CVI_00250_09
crossref_primary_10_1186_1476_8518_8_4
crossref_primary_10_1016_j_vaccine_2009_01_117
crossref_primary_10_1637_11202_052815_Reg_1
crossref_primary_10_1007_s00441_018_2929_4
crossref_primary_10_1038_emi_2012_17
crossref_primary_10_1016_j_hlife_2023_12_005
crossref_primary_10_1016_j_vaccine_2014_03_014
crossref_primary_10_1021_acs_molpharmaceut_0c00487
crossref_primary_10_1016_j_vetimm_2019_02_004
crossref_primary_10_1039_D3BM01970E
crossref_primary_10_1586_erv_10_89
crossref_primary_10_1016_j_vaccine_2010_09_080
crossref_primary_10_1016_j_exppara_2012_05_002
crossref_primary_10_7774_cevr_2015_4_1_23
crossref_primary_10_1002_jat_1683
crossref_primary_10_1016_j_vetimm_2016_05_003
crossref_primary_10_1016_j_antiviral_2015_01_007
crossref_primary_10_1016_j_vaccine_2010_10_006
crossref_primary_10_1134_S1070363217050188
crossref_primary_10_1016_j_vetimm_2012_01_021
crossref_primary_10_3390_vaccines2030500
crossref_primary_10_1016_j_vaccine_2018_02_026
crossref_primary_10_1098_rsif_2012_0536
crossref_primary_10_3390_vaccines8020235
crossref_primary_10_1586_erv_10_154
crossref_primary_10_1021_acs_molpharmaceut_2c00489
crossref_primary_10_1016_j_vaccine_2011_09_062
crossref_primary_10_1016_j_jiec_2019_04_044
crossref_primary_10_3390_vaccines10060927
crossref_primary_10_1016_j_vaccine_2009_12_069
crossref_primary_10_1016_j_molimm_2012_03_026
crossref_primary_10_1016_j_ejpb_2010_12_017
crossref_primary_10_1016_j_vaccine_2013_06_058
crossref_primary_10_1016_j_vaccine_2009_02_016
crossref_primary_10_3389_fbioe_2021_625482
crossref_primary_10_4155_tde_10_19
crossref_primary_10_1016_j_cca_2011_01_006
crossref_primary_10_1016_j_nano_2017_05_012
crossref_primary_10_1016_j_ijpharm_2019_118731
crossref_primary_10_1016_j_jconrel_2020_12_001
crossref_primary_10_3389_fimmu_2017_00037
crossref_primary_10_3390_vaccines9050507
Cites_doi 10.1006/clin.1997.4380
10.1016/j.vaccine.2007.11.054
10.4049/jimmunol.160.2.870
10.4049/jimmunol.136.12.4538
10.1016/j.vaccine.2006.10.011
10.1016/j.vaccine.2003.09.030
10.1016/S0264-410X(03)00003-3
10.1016/S0264-410X(98)00157-1
10.1006/cimm.1996.0009
10.1016/S0264-410X(98)00359-4
10.1093/intimm/5.8.885
10.4049/jimmunol.162.9.5536
10.1016/j.vaccine.2005.06.024
10.1016/S0264-410X(97)00149-7
10.1016/S0264-410X(02)00169-X
10.1093/intimm/dxg049
10.1126/science.272.5258.50
10.1021/bm049329t
10.1097/01.aids.0000183514.37513.d2
10.1126/science.3107127
10.1128/IAI.69.12.7695-7702.2001
10.4049/jimmunol.162.7.3942
10.1016/S0264-410X(02)00378-X
10.1146/annurev.iy.08.040190.001511
10.1128/JVI.76.18.9002-9010.2002
10.1016/S1389-0344(01)00101-0
10.1073/pnas.93.7.2879
10.1146/annurev.immunol.15.1.297
10.1146/annurev.immunol.21.120601.140942
10.1016/S0169-409X(01)00170-3
10.1038/nri1001
ContentType Journal Article
Copyright Elsevier Ltd
2008 Elsevier Ltd
2008 INIST-CNRS
Copyright Elsevier Limited May 23, 2008
Copyright_xml – notice: Elsevier Ltd
– notice: 2008 Elsevier Ltd
– notice: 2008 INIST-CNRS
– notice: Copyright Elsevier Limited May 23, 2008
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7QL
7RV
7T2
7T5
7U9
7X7
7XB
88C
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
H94
HCIFZ
K9-
K9.
KB0
LK8
M0R
M0S
M0T
M1P
M2O
M7N
M7P
MBDVC
NAPCQ
PQEST
PQQKQ
PQUKI
Q9U
DOI 10.1016/j.vaccine.2008.03.031
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Nursing & Allied Health Database
Health and Safety Science Abstracts (Full archive)
Immunology Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Healthcare Administration Database (Alumni)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
AIDS and Cancer Research Abstracts
SciTech Premium Collection
Consumer Health Database (Alumni Edition)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Biological Science Collection
Consumer Health Database
Health & Medical Collection (Alumni Edition)
Healthcare Administration Database
PML(ProQuest Medical Library)
Research Library
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central Basic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
Environmental Sciences and Pollution Management
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Research Library
Health & Safety Science Abstracts
ProQuest Medical Library (Alumni)
ProQuest Public Health
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Health Management
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Health Management (Alumni Edition)
Immunology Abstracts
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest Central (Alumni)
DatabaseTitleList MEDLINE
Research Library Prep


AIDS and Cancer Research Abstracts
AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Veterinary Medicine
Biology
Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-2518
EndPage 2688
ExternalDocumentID 3419607261
10_1016_j_vaccine_2008_03_031
18430493
20328867
S0264410X08003320
1_s2_0_S0264410X08003320
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
0SF
123
1B1
1P~
1RT
1~.
1~5
29Q
3V.
4.4
457
4G.
53G
5RE
5VS
7-5
71M
7RV
7X7
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8P~
9JM
AAAJQ
AABNK
AACTN
AAEDT
AAEDW
AAHBH
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AAXKI
AAXUO
ABBQC
ABFNM
ABFRF
ABJNI
ABKYH
ABMAC
ABMZM
ABRWV
ABUWG
ABXDB
ACDAQ
ACGFO
ACGFS
ACIUM
ACPRK
ACRLP
ADBBV
ADEZE
ADFRT
ADMUD
ADVLN
AEBSH
AEFWE
AEKER
AENEX
AEVXI
AEXOQ
AFCTW
AFJKZ
AFKRA
AFKWA
AFRAH
AFRHN
AFTJW
AFXIZ
AGEKW
AGGSO
AGHFR
AGUBO
AGYEJ
AHHHB
AHMBA
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
AJUYK
AKRWK
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AQUVI
ASPBG
AVWKF
AXJTR
AZFZN
AZQEC
BBNVY
BENPR
BHPHI
BKEYQ
BKNYI
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
CCPQU
CJTIS
CNWQP
CS3
DWQXO
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
FYUFA
G-2
G-Q
GBLVA
GNUQQ
GUQSH
HCIFZ
HEJ
HLV
HMG
HMK
HMO
HVGLF
HX~
HZ~
IHE
J1W
K9-
KOM
L7B
LK8
LUGTX
LW9
M0R
M0T
M1P
M29
M2O
M41
M7P
MO0
N9A
NAPCQ
O-L
O9-
O9~
OAUVE
OK0
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
PSQYO
Q38
R2-
RIG
ROL
RPZ
SAB
SAE
SCC
SDF
SDG
SDP
SES
SEW
SIN
SNL
SPCBC
SSH
SSI
SSZ
SVS
T5K
UV1
WH7
WOW
WUQ
XPP
Z5R
ZGI
ZXP
~G-
AAIAV
ABLVK
ABYKQ
AESVU
AJBFU
EFLBG
HMCUK
LCYCR
QYZTP
UKHRP
ABPIF
ABPTK
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QL
7T2
7T5
7U9
7XB
8FK
C1K
H94
K9.
M7N
MBDVC
PQEST
PQUKI
Q9U
ID FETCH-LOGICAL-c540t-89ceb49023ac36aaa5a3308e8dc8b76e541d2d08b51058fe5acb8f2d3a21750b3
ISSN 0264-410X
IngestDate Fri Oct 25 23:10:56 EDT 2024
Thu Oct 24 23:50:39 EDT 2024
Fri Nov 08 08:08:47 EST 2024
Thu Sep 26 18:01:58 EDT 2024
Sat Sep 28 07:54:45 EDT 2024
Sun Oct 22 16:06:05 EDT 2023
Fri Feb 23 02:32:31 EST 2024
Tue Oct 15 22:55:52 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 22
Keywords Polyphosphazenes
PCPP
Adjuvants
HBsAg
PCEP
CpG ODN
Vaccines
Immunization
Hepatitis B surface antigen
Immune response
Rodentia
Orthohepadnavirus
Vaccine
Virus
Vertebrata
Mammalia
Mouse
Hepadnaviridae
Immunological adjuvant
Hepatitis B virus
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c540t-89ceb49023ac36aaa5a3308e8dc8b76e541d2d08b51058fe5acb8f2d3a21750b3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
PMID 18430493
PQID 1558814784
PQPubID 23462
PageCount 9
ParticipantIDs proquest_miscellaneous_20979012
proquest_miscellaneous_1500788148
proquest_journals_1558814784
crossref_primary_10_1016_j_vaccine_2008_03_031
pubmed_primary_18430493
pascalfrancis_primary_20328867
elsevier_sciencedirect_doi_10_1016_j_vaccine_2008_03_031
elsevier_clinicalkeyesjournals_1_s2_0_S0264410X08003320
PublicationCentury 2000
PublicationDate 2008-05-23
PublicationDateYYYYMMDD 2008-05-23
PublicationDate_xml – month: 05
  year: 2008
  text: 2008-05-23
  day: 23
PublicationDecade 2000
PublicationPlace Oxford
PublicationPlace_xml – name: Oxford
– name: Netherlands
– name: Kidlington
PublicationTitle Vaccine
PublicationTitleAlternate Vaccine
PublicationYear 2008
Publisher Elsevier Ltd
Elsevier
Elsevier Limited
Publisher_xml – name: Elsevier Ltd
– name: Elsevier
– name: Elsevier Limited
References Arulanandam, Metzger (bib29) 1999; 17
Boyaka, McGhee (bib24) 2001; 51
Coffman, Ohara, Bond, Carty, Zlotnik, Paul (bib32) 1986; 136
Collins, Dunnick (bib31) 1993; 5
McNeal, Rae, Ward (bib13) 1999; 17
Cribbs, Ghochikyan, Vasilevko, Tran, Petrushina, Sadzikava (bib19) 2003; 15
Wack, Baudner, Hilbert, Manini, Nuti, Tavarini (bib11) 2008; 26
Chace, Hooker, Mildenstein, Krieg, Cowdery (bib34) 1997; 84
Snapper, Paul (bib30) 1987; 236
Weeratna, Makinen, McCluskie, Davis (bib27) 2005; 23
Halpern, Kurlander, Pisetsky (bib33) 1996; 167
Klinman, Yi, Beaucage, Conover, Krieg (bib4) 1996; 93
HogenEsch (bib10) 2002; 20
Constant, Bottomly (bib18) 1997; 15
Mazumdar, Anam, Ali (bib20) 2004; 22
Trinchieri (bib28) 2003; 3
Smith, Donachie, Grdic, Lycke, Mowat (bib26) 1999; 162
Ramon (bib1) 1924; 38
Mutwiri, Benjamin, Soita, Townsend, Yost, Roberts (bib15) 2007; 25
Yip, Karulin, Tary-Lehmann, Hesse, Radeke, Heeger (bib21) 1999; 162
Fearon, Locksley (bib3) 1996; 272
Szabo, Sullivan, Peng, Glimcher (bib23) 2003; 21
Cooper, Davis, Angel, Morris, Elfer, Seguin (bib5) 2005; 19
Alcon, Foldvari, Snider, Willson, Gomis, Hecker (bib6) 2003; 21
Andrianov, Marin, Roberts (bib16) 2005; 6
Payne, Jenkins, Woods, Grund, Geribo, Loebelenz (bib12) 1998; 16
Finkelman, Holmes, Katona, Urban, Beckmann, Park (bib22) 1990; 8
Heath (bib25) 1995
Wu, Wade, Taylor (bib14) 2001; 69
Davis, Weeratna, Waldschmidt, Tygrett, Schorr, Krieg (bib7) 1998; 160
Ioannou, Griebel, Hecker, Babiuk, van Drunen Littel-van den Hurk (bib8) 2002; 76
Andrianov, Svirkin, LeGolvan (bib17) 2004; 5
O’Hagan, MacKichan, Singh (bib2) 2001; 18
Ioannou, Gomis, Karvonen, Hecker, Babiuk, van Drunen Littel-van den Hurk (bib9) 2002; 21
Payne (10.1016/j.vaccine.2008.03.031_bib12) 1998; 16
Cribbs (10.1016/j.vaccine.2008.03.031_bib19) 2003; 15
Heath (10.1016/j.vaccine.2008.03.031_bib25) 1995
McNeal (10.1016/j.vaccine.2008.03.031_bib13) 1999; 17
Szabo (10.1016/j.vaccine.2008.03.031_bib23) 2003; 21
Coffman (10.1016/j.vaccine.2008.03.031_bib32) 1986; 136
Boyaka (10.1016/j.vaccine.2008.03.031_bib24) 2001; 51
Collins (10.1016/j.vaccine.2008.03.031_bib31) 1993; 5
Finkelman (10.1016/j.vaccine.2008.03.031_bib22) 1990; 8
Smith (10.1016/j.vaccine.2008.03.031_bib26) 1999; 162
Trinchieri (10.1016/j.vaccine.2008.03.031_bib28) 2003; 3
Chace (10.1016/j.vaccine.2008.03.031_bib34) 1997; 84
Davis (10.1016/j.vaccine.2008.03.031_bib7) 1998; 160
Constant (10.1016/j.vaccine.2008.03.031_bib18) 1997; 15
Ramon (10.1016/j.vaccine.2008.03.031_bib1) 1924; 38
O’Hagan (10.1016/j.vaccine.2008.03.031_bib2) 2001; 18
Wack (10.1016/j.vaccine.2008.03.031_bib11) 2008; 26
Wu (10.1016/j.vaccine.2008.03.031_bib14) 2001; 69
Arulanandam (10.1016/j.vaccine.2008.03.031_bib29) 1999; 17
Yip (10.1016/j.vaccine.2008.03.031_bib21) 1999; 162
Ioannou (10.1016/j.vaccine.2008.03.031_bib9) 2002; 21
HogenEsch (10.1016/j.vaccine.2008.03.031_bib10) 2002; 20
Ioannou (10.1016/j.vaccine.2008.03.031_bib8) 2002; 76
Mutwiri (10.1016/j.vaccine.2008.03.031_bib15) 2007; 25
Klinman (10.1016/j.vaccine.2008.03.031_bib4) 1996; 93
Cooper (10.1016/j.vaccine.2008.03.031_bib5) 2005; 19
Mazumdar (10.1016/j.vaccine.2008.03.031_bib20) 2004; 22
Snapper (10.1016/j.vaccine.2008.03.031_bib30) 1987; 236
Fearon (10.1016/j.vaccine.2008.03.031_bib3) 1996; 272
Andrianov (10.1016/j.vaccine.2008.03.031_bib17) 2004; 5
Alcon (10.1016/j.vaccine.2008.03.031_bib6) 2003; 21
Andrianov (10.1016/j.vaccine.2008.03.031_bib16) 2005; 6
Halpern (10.1016/j.vaccine.2008.03.031_bib33) 1996; 167
Weeratna (10.1016/j.vaccine.2008.03.031_bib27) 2005; 23
References_xml – volume: 38
  start-page: 1
  year: 1924
  ident: bib1
  publication-title: Ann Inst Pasteur
  contributor:
    fullname: Ramon
– volume: 25
  start-page: 1204
  year: 2007
  end-page: 1213
  ident: bib15
  article-title: Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) is a potent enhancer of mixed Th1/Th2 immune responses in mice immunized with influenza virus antigens
  publication-title: Vaccine
  contributor:
    fullname: Roberts
– volume: 5
  start-page: 885
  year: 1993
  end-page: 891
  ident: bib31
  article-title: Germline transcripts of the murine immunoglobulin gamma 2a gene: structure and induction by IFN-gamma
  publication-title: Int Immunol
  contributor:
    fullname: Dunnick
– volume: 76
  start-page: 9002
  year: 2002
  end-page: 9010
  ident: bib8
  article-title: The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides
  publication-title: J Virol
  contributor:
    fullname: van Drunen Littel-van den Hurk
– volume: 162
  start-page: 3942
  year: 1999
  end-page: 3949
  ident: bib21
  article-title: Adjuvant-guided type-1 and type-2 immunity: infectious/noninfectious dichotomy defines the class of response
  publication-title: J Immunol
  contributor:
    fullname: Heeger
– volume: 160
  start-page: 870
  year: 1998
  end-page: 876
  ident: bib7
  article-title: CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen
  publication-title: J Immunol
  contributor:
    fullname: Krieg
– volume: 167
  start-page: 72
  year: 1996
  end-page: 78
  ident: bib33
  article-title: Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha
  publication-title: Cell Immunol
  contributor:
    fullname: Pisetsky
– volume: 21
  start-page: 713
  year: 2003
  end-page: 758
  ident: bib23
  article-title: Molecular mechanisms regulating Th1 immune responses
  publication-title: Annu Rev Immunol
  contributor:
    fullname: Glimcher
– volume: 162
  start-page: 5536
  year: 1999
  end-page: 5546
  ident: bib26
  article-title: Immune-stimulating complexes induce an IL-12-dependent cascade of innate immune responses
  publication-title: J Immunol
  contributor:
    fullname: Mowat
– volume: 51
  start-page: 71
  year: 2001
  end-page: 79
  ident: bib24
  article-title: Cytokines as adjuvants for the induction of mucosal immunity
  publication-title: Adv Drug Deliv Rev
  contributor:
    fullname: McGhee
– volume: 236
  start-page: 944
  year: 1987
  end-page: 947
  ident: bib30
  article-title: Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production
  publication-title: Science
  contributor:
    fullname: Paul
– volume: 84
  start-page: 185
  year: 1997
  end-page: 193
  ident: bib34
  article-title: Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12
  publication-title: Clin Immunol Immunopathol
  contributor:
    fullname: Cowdery
– year: 1995
  ident: bib25
  article-title: Cytokines as immunological adjuvants
  contributor:
    fullname: Heath
– volume: 26
  start-page: 552
  year: 2008
  end-page: 561
  ident: bib11
  article-title: Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice
  publication-title: Vaccine
  contributor:
    fullname: Tavarini
– volume: 23
  start-page: 5263
  year: 2005
  end-page: 5270
  ident: bib27
  article-title: TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848)
  publication-title: Vaccine
  contributor:
    fullname: Davis
– volume: 20
  start-page: S34
  year: 2002
  end-page: S39
  ident: bib10
  article-title: Mechanisms of stimulation of the immune response by aluminum adjuvants
  publication-title: Vaccine
  contributor:
    fullname: HogenEsch
– volume: 22
  start-page: 1162
  year: 2004
  end-page: 1171
  ident: bib20
  article-title: A mixed Th1/Th2 response elicited by a liposomal formulation of
  publication-title: Vaccine
  contributor:
    fullname: Ali
– volume: 69
  start-page: 7695
  year: 2001
  end-page: 7702
  ident: bib14
  article-title: Evaluation of cholera vaccines formulated with toxin-coregulated pilin peptide plus polymer adjuvant in mice
  publication-title: Infect Immun
  contributor:
    fullname: Taylor
– volume: 6
  start-page: 1375
  year: 2005
  end-page: 1379
  ident: bib16
  article-title: Polyphosphazene polyelectrolytes: a link between the formation of noncovalent complexes with antigenic proteins and immunostimulating activity
  publication-title: Biomacromolecules
  contributor:
    fullname: Roberts
– volume: 21
  start-page: 127
  year: 2002
  end-page: 137
  ident: bib9
  article-title: CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein
  publication-title: Vaccine
  contributor:
    fullname: van Drunen Littel-van den Hurk
– volume: 17
  start-page: 1573
  year: 1999
  end-page: 1580
  ident: bib13
  article-title: Effects of different adjuvants on rotavirus antibody responses and protection in mice following intramuscular immunization with inactivated rotavirus
  publication-title: Vaccine
  contributor:
    fullname: Ward
– volume: 136
  start-page: 4538
  year: 1986
  end-page: 4541
  ident: bib32
  article-title: B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells
  publication-title: J Immunol
  contributor:
    fullname: Paul
– volume: 93
  start-page: 2879
  year: 1996
  end-page: 2883
  ident: bib4
  article-title: CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma
  publication-title: Proc Natl Acad Sci USA
  contributor:
    fullname: Krieg
– volume: 18
  start-page: 69
  year: 2001
  end-page: 85
  ident: bib2
  article-title: Recent developments in adjuvants for vaccines against infectious diseases
  publication-title: Biomol Eng
  contributor:
    fullname: Singh
– volume: 21
  start-page: 1811
  year: 2003
  end-page: 1814
  ident: bib6
  article-title: Induction of protective immunity in pigs after immunisation with CpG oligodeoxynucleotides formulated in a lipid-based delivery system (Biphasix)
  publication-title: Vaccine
  contributor:
    fullname: Hecker
– volume: 15
  start-page: 505
  year: 2003
  end-page: 514
  ident: bib19
  article-title: Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid
  publication-title: Int Immunol
  contributor:
    fullname: Sadzikava
– volume: 272
  start-page: 50
  year: 1996
  end-page: 53
  ident: bib3
  article-title: The instructive role of innate immunity in the acquired immune response
  publication-title: Science
  contributor:
    fullname: Locksley
– volume: 17
  start-page: 252
  year: 1999
  end-page: 260
  ident: bib29
  article-title: Modulation of mucosal and systemic immunity by intranasal interleukin 12 delivery
  publication-title: Vaccine
  contributor:
    fullname: Metzger
– volume: 16
  start-page: 92
  year: 1998
  end-page: 98
  ident: bib12
  article-title: Poly[di(carboxylatophenoxy)phosphazene] (PCPP) is a potent immunoadjuvant for an influenza vaccine
  publication-title: Vaccine
  contributor:
    fullname: Loebelenz
– volume: 5
  start-page: 1999
  year: 2004
  end-page: 2006
  ident: bib17
  article-title: Synthesis and biologically relevant properties of polyphosphazene polyacids
  publication-title: Biomolecules
  contributor:
    fullname: LeGolvan
– volume: 19
  start-page: 1473
  year: 2005
  end-page: 1479
  ident: bib5
  article-title: CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults
  publication-title: AIDS
  contributor:
    fullname: Seguin
– volume: 3
  start-page: 133
  year: 2003
  end-page: 146
  ident: bib28
  article-title: Interleukin-12 and the regulation of innate resistance and adaptive immunity
  publication-title: Nat Rev Immunol
  contributor:
    fullname: Trinchieri
– volume: 15
  start-page: 297
  year: 1997
  end-page: 322
  ident: bib18
  article-title: Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches
  publication-title: Annu Rev Immunol
  contributor:
    fullname: Bottomly
– volume: 8
  start-page: 303
  year: 1990
  end-page: 333
  ident: bib22
  article-title: Lymphokine control of in vivo immunoglobulin isotype selection
  publication-title: Annu Rev Immunol
  contributor:
    fullname: Park
– volume: 84
  start-page: 185
  issue: 2
  year: 1997
  ident: 10.1016/j.vaccine.2008.03.031_bib34
  article-title: Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12
  publication-title: Clin Immunol Immunopathol
  doi: 10.1006/clin.1997.4380
  contributor:
    fullname: Chace
– volume: 26
  start-page: 552
  issue: 4
  year: 2008
  ident: 10.1016/j.vaccine.2008.03.031_bib11
  article-title: Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2007.11.054
  contributor:
    fullname: Wack
– year: 1995
  ident: 10.1016/j.vaccine.2008.03.031_bib25
  contributor:
    fullname: Heath
– volume: 38
  start-page: 1
  year: 1924
  ident: 10.1016/j.vaccine.2008.03.031_bib1
  publication-title: Ann Inst Pasteur
  contributor:
    fullname: Ramon
– volume: 160
  start-page: 870
  issue: 2
  year: 1998
  ident: 10.1016/j.vaccine.2008.03.031_bib7
  article-title: CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen
  publication-title: J Immunol
  doi: 10.4049/jimmunol.160.2.870
  contributor:
    fullname: Davis
– volume: 136
  start-page: 4538
  issue: 12
  year: 1986
  ident: 10.1016/j.vaccine.2008.03.031_bib32
  article-title: B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells
  publication-title: J Immunol
  doi: 10.4049/jimmunol.136.12.4538
  contributor:
    fullname: Coffman
– volume: 25
  start-page: 1204
  issue: 7
  year: 2007
  ident: 10.1016/j.vaccine.2008.03.031_bib15
  article-title: Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) is a potent enhancer of mixed Th1/Th2 immune responses in mice immunized with influenza virus antigens
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2006.10.011
  contributor:
    fullname: Mutwiri
– volume: 22
  start-page: 1162
  issue: 9–10
  year: 2004
  ident: 10.1016/j.vaccine.2008.03.031_bib20
  article-title: A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2003.09.030
  contributor:
    fullname: Mazumdar
– volume: 21
  start-page: 1811
  issue: 17–18
  year: 2003
  ident: 10.1016/j.vaccine.2008.03.031_bib6
  article-title: Induction of protective immunity in pigs after immunisation with CpG oligodeoxynucleotides formulated in a lipid-based delivery system (Biphasix)
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(03)00003-3
  contributor:
    fullname: Alcon
– volume: 17
  start-page: 252
  issue: 3
  year: 1999
  ident: 10.1016/j.vaccine.2008.03.031_bib29
  article-title: Modulation of mucosal and systemic immunity by intranasal interleukin 12 delivery
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(98)00157-1
  contributor:
    fullname: Arulanandam
– volume: 167
  start-page: 72
  issue: 1
  year: 1996
  ident: 10.1016/j.vaccine.2008.03.031_bib33
  article-title: Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha
  publication-title: Cell Immunol
  doi: 10.1006/cimm.1996.0009
  contributor:
    fullname: Halpern
– volume: 17
  start-page: 1573
  issue: 11–12
  year: 1999
  ident: 10.1016/j.vaccine.2008.03.031_bib13
  article-title: Effects of different adjuvants on rotavirus antibody responses and protection in mice following intramuscular immunization with inactivated rotavirus
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(98)00359-4
  contributor:
    fullname: McNeal
– volume: 5
  start-page: 885
  issue: 8
  year: 1993
  ident: 10.1016/j.vaccine.2008.03.031_bib31
  article-title: Germline transcripts of the murine immunoglobulin gamma 2a gene: structure and induction by IFN-gamma
  publication-title: Int Immunol
  doi: 10.1093/intimm/5.8.885
  contributor:
    fullname: Collins
– volume: 162
  start-page: 5536
  issue: 9
  year: 1999
  ident: 10.1016/j.vaccine.2008.03.031_bib26
  article-title: Immune-stimulating complexes induce an IL-12-dependent cascade of innate immune responses
  publication-title: J Immunol
  doi: 10.4049/jimmunol.162.9.5536
  contributor:
    fullname: Smith
– volume: 23
  start-page: 5263
  issue: 45
  year: 2005
  ident: 10.1016/j.vaccine.2008.03.031_bib27
  article-title: TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848)
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2005.06.024
  contributor:
    fullname: Weeratna
– volume: 16
  start-page: 92
  issue: 1
  year: 1998
  ident: 10.1016/j.vaccine.2008.03.031_bib12
  article-title: Poly[di(carboxylatophenoxy)phosphazene] (PCPP) is a potent immunoadjuvant for an influenza vaccine
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(97)00149-7
  contributor:
    fullname: Payne
– volume: 20
  start-page: S34
  issue: Suppl. 3
  year: 2002
  ident: 10.1016/j.vaccine.2008.03.031_bib10
  article-title: Mechanisms of stimulation of the immune response by aluminum adjuvants
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(02)00169-X
  contributor:
    fullname: HogenEsch
– volume: 15
  start-page: 505
  issue: 4
  year: 2003
  ident: 10.1016/j.vaccine.2008.03.031_bib19
  article-title: Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid
  publication-title: Int Immunol
  doi: 10.1093/intimm/dxg049
  contributor:
    fullname: Cribbs
– volume: 272
  start-page: 50
  issue: 5258
  year: 1996
  ident: 10.1016/j.vaccine.2008.03.031_bib3
  article-title: The instructive role of innate immunity in the acquired immune response
  publication-title: Science
  doi: 10.1126/science.272.5258.50
  contributor:
    fullname: Fearon
– volume: 6
  start-page: 1375
  issue: 3
  year: 2005
  ident: 10.1016/j.vaccine.2008.03.031_bib16
  article-title: Polyphosphazene polyelectrolytes: a link between the formation of noncovalent complexes with antigenic proteins and immunostimulating activity
  publication-title: Biomacromolecules
  doi: 10.1021/bm049329t
  contributor:
    fullname: Andrianov
– volume: 19
  start-page: 1473
  issue: 14
  year: 2005
  ident: 10.1016/j.vaccine.2008.03.031_bib5
  article-title: CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults
  publication-title: AIDS
  doi: 10.1097/01.aids.0000183514.37513.d2
  contributor:
    fullname: Cooper
– volume: 236
  start-page: 944
  issue: 4804
  year: 1987
  ident: 10.1016/j.vaccine.2008.03.031_bib30
  article-title: Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production
  publication-title: Science
  doi: 10.1126/science.3107127
  contributor:
    fullname: Snapper
– volume: 69
  start-page: 7695
  issue: 12
  year: 2001
  ident: 10.1016/j.vaccine.2008.03.031_bib14
  article-title: Evaluation of cholera vaccines formulated with toxin-coregulated pilin peptide plus polymer adjuvant in mice
  publication-title: Infect Immun
  doi: 10.1128/IAI.69.12.7695-7702.2001
  contributor:
    fullname: Wu
– volume: 162
  start-page: 3942
  issue: 7
  year: 1999
  ident: 10.1016/j.vaccine.2008.03.031_bib21
  article-title: Adjuvant-guided type-1 and type-2 immunity: infectious/noninfectious dichotomy defines the class of response
  publication-title: J Immunol
  doi: 10.4049/jimmunol.162.7.3942
  contributor:
    fullname: Yip
– volume: 21
  start-page: 127
  issue: 1–2
  year: 2002
  ident: 10.1016/j.vaccine.2008.03.031_bib9
  article-title: CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(02)00378-X
  contributor:
    fullname: Ioannou
– volume: 8
  start-page: 303
  year: 1990
  ident: 10.1016/j.vaccine.2008.03.031_bib22
  article-title: Lymphokine control of in vivo immunoglobulin isotype selection
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.iy.08.040190.001511
  contributor:
    fullname: Finkelman
– volume: 76
  start-page: 9002
  issue: 18
  year: 2002
  ident: 10.1016/j.vaccine.2008.03.031_bib8
  article-title: The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides
  publication-title: J Virol
  doi: 10.1128/JVI.76.18.9002-9010.2002
  contributor:
    fullname: Ioannou
– volume: 18
  start-page: 69
  issue: 3
  year: 2001
  ident: 10.1016/j.vaccine.2008.03.031_bib2
  article-title: Recent developments in adjuvants for vaccines against infectious diseases
  publication-title: Biomol Eng
  doi: 10.1016/S1389-0344(01)00101-0
  contributor:
    fullname: O’Hagan
– volume: 93
  start-page: 2879
  issue: 7
  year: 1996
  ident: 10.1016/j.vaccine.2008.03.031_bib4
  article-title: CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.93.7.2879
  contributor:
    fullname: Klinman
– volume: 15
  start-page: 297
  year: 1997
  ident: 10.1016/j.vaccine.2008.03.031_bib18
  article-title: Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.immunol.15.1.297
  contributor:
    fullname: Constant
– volume: 21
  start-page: 713
  year: 2003
  ident: 10.1016/j.vaccine.2008.03.031_bib23
  article-title: Molecular mechanisms regulating Th1 immune responses
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.immunol.21.120601.140942
  contributor:
    fullname: Szabo
– volume: 5
  start-page: 1999
  year: 2004
  ident: 10.1016/j.vaccine.2008.03.031_bib17
  article-title: Synthesis and biologically relevant properties of polyphosphazene polyacids
  publication-title: Biomolecules
  contributor:
    fullname: Andrianov
– volume: 51
  start-page: 71
  issue: 1–3
  year: 2001
  ident: 10.1016/j.vaccine.2008.03.031_bib24
  article-title: Cytokines as adjuvants for the induction of mucosal immunity
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/S0169-409X(01)00170-3
  contributor:
    fullname: Boyaka
– volume: 3
  start-page: 133
  issue: 2
  year: 2003
  ident: 10.1016/j.vaccine.2008.03.031_bib28
  article-title: Interleukin-12 and the regulation of innate resistance and adaptive immunity
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri1001
  contributor:
    fullname: Trinchieri
SSID ssj0005319
Score 2.1816041
Snippet Summary An emerging paradigm in vaccinology is that multiple adjuvant combinations may be more effective than individual adjuvants in enhancing immune...
An emerging paradigm in vaccinology is that multiple adjuvant combinations may be more effective than individual adjuvants in enhancing immune responses to...
SourceID proquest
crossref
pubmed
pascalfrancis
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 2680
SubjectTerms Adjuvants
Adjuvants, Immunologic - administration & dosage
Allergy and Immunology
Animals
Applied microbiology
Biological and medical sciences
Cells, Cultured
CpG ODN
Drug Synergism
Fundamental and applied biological sciences. Psychology
HBsAg
Hepatitis
Hepatitis B Antibodies - blood
Hepatitis B Surface Antigens - immunology
Hepatitis B Vaccines - immunology
Hepatitis B virus
Immune system
Immunization
Immunoglobulin G - blood
Injections, Subcutaneous
Interferon-gamma - biosynthesis
Interleukin-12 - biosynthesis
Interleukin-2 - biosynthesis
Laboratories
Leukocytes, Mononuclear - immunology
Medical research
Mice
Mice, Inbred BALB C
Microbiology
Miscellaneous
Oligodeoxyribonucleotides - administration & dosage
Oligodeoxyribonucleotides - immunology
Organophosphorus Compounds - administration & dosage
Organophosphorus Compounds - immunology
PCEP
PCPP
Polymers - administration & dosage
Polyphosphazenes
Rodents
Sodium
Vaccines
Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
Virology
Title Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0264410X08003320
https://dx.doi.org/10.1016/j.vaccine.2008.03.031
https://www.ncbi.nlm.nih.gov/pubmed/18430493
https://www.proquest.com/docview/1558814784
https://search.proquest.com/docview/1500788148
https://search.proquest.com/docview/20979012
Volume 26
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1tT9RAEN4ARmNijJ6ip4hrYvhy9Nzubq97HwFRvmCIICF-abbtVkqwvVyv6PFr_KnOdPsCAvElMWmau76383R2ZvrMDCGvJQ9DHMccMTbKkTqJnbF2Q0dFETcyjBPNMd95Z9__cKTebsvthYWmcUG37L9KGpaBrDFz9i-k3R4UFsBvkDnMQeow_yO5b-WOvlQQt-I056fzyXFeTI71OSo3G37dmrwf5KcpeKYm_z7PsLJxPktjWF1ggPzL6XxgsmOERTFIMY8EW6xUlNqKxTXATvZ2RXresNh3DFK0Z2kx2BycpdMSjlVOE12lJcyw8udFa_hQRxe_6--Ws2-pzXy3ofo2VmCyE_3VVjvYy7MWz_t5ao3fKtWiC8qGaWnbw-dTuOaN4aXQhsKv8jb72MbbmpybjuBUVKVipSNddmRHMKu2lS8csNTURb1uM_Fr_Nrk50ZLj2z3qHrEh7_q2tHEBjZOhmf2adTMWwGT2w2fLalxn1XGJTtCI1wIzhbJLQ7qD4mmn72PHfFIVO1m2vvo8sreXHuqmyymexNdwHuc2AYsN3tIlaV08IDcr10cumGx-ZAsmKxHbtump_MeubNb0zl6ZG3PFk6fr9ODLg-wWKdrdK8rqQ779A6RtVWljtNm90fkxxWs0zyhv2KdIi4pYJ1ei3XaYJ02WKcW67TFOk0zilinLdbtMVus001aYZ3WWKc11h-TT--2D7Z2nLrjiBOB5zJz1DgyoRyDHasjMdJae1oIpoyKIxX6I-NJN-YxUyG6JSoxno5ClfBYaPDsPRaKZbKU5Zl5SqhnsJIji5lIYulKNeYsDjUovxFnPBKqT4aNVIOJLSwTNIzLk6CGQd0kVsDk9onfyD5osqZhnDdFrXyKwA0KHrDgCg77RLV71na1tZcDAPrvTrp6CWXtpXKsw6lGfp-sNLALugvxPKVc6SvZJ6_a1TBu4cdInZm8xG3QO4Gt4Em8vGEbzsY--Cu8T55YQHdPSknkB4hn_35rz8ndTueskKXZtDQvyGIRl6vV-_oTDz0xJw
link.rule.ids 315,782,786,27935,27936
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Co-administration+of+polyphosphazenes+with+CpG+oligodeoxynucleotides+strongly+enhances+immune+responses+in+mice+immunized+with+Hepatitis+B+virus+surface+antigen&rft.jtitle=Vaccine&rft.au=Mutwiri%2C+George&rft.au=Benjamin%2C+Ponn&rft.au=Soita%2C+Henry&rft.au=Babiuk%2C+Lorne+A.&rft.date=2008-05-23&rft.pub=Elsevier+Ltd&rft.issn=0264-410X&rft.eissn=1873-2518&rft.volume=26&rft.issue=22&rft.spage=2680&rft.epage=2688&rft_id=info:doi/10.1016%2Fj.vaccine.2008.03.031&rft.externalDocID=S0264410X08003320
thumbnail_m http://sdu.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F0264410X%2FS0264410X08X00210%2Fcov150h.gif